IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 366 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $9,000 | -18.2% | 200 | 0.0% | 0.00% | – |
Q2 2020 | $11,000 | -71.1% | 200 | -69.0% | 0.00% | – |
Q1 2020 | $38,000 | 0.0% | 646 | 0.0% | 0.00% | – |
Q4 2019 | $38,000 | +245.5% | 646 | +213.6% | 0.00% | – |
Q3 2019 | $11,000 | -8.3% | 206 | 0.0% | 0.00% | – |
Q2 2019 | $12,000 | -25.0% | 206 | 0.0% | 0.00% | – |
Q1 2019 | $16,000 | +45.5% | 206 | -6.8% | 0.00% | – |
Q4 2018 | $11,000 | +10.0% | 221 | +10.5% | 0.00% | – |
Q3 2018 | $10,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2018 | $10,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q4 2017 | $10,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q3 2017 | $10,000 | -65.5% | 200 | -72.4% | 0.00% | – |
Q2 2017 | $29,000 | 0.0% | 724 | 0.0% | 0.00% | – |
Q1 2017 | $29,000 | -12.1% | 724 | +2.0% | 0.00% | – |
Q4 2016 | $33,000 | +32.0% | 710 | 0.0% | 0.00% | – |
Q3 2016 | $25,000 | -34.2% | 710 | -58.5% | 0.00% | – |
Q2 2016 | $38,000 | +850.0% | 1,710 | +1454.5% | 0.00% | – |
Q1 2016 | $4,000 | -33.3% | 110 | 0.0% | 0.00% | – |
Q4 2015 | $6,000 | – | 110 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |